Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Post by rhdmdon Jun 05, 2013 8:26pm
155 Views
Post# 21489456

How can we afford

How can we afford

the Trials cost of Urocidin? Note under this deal, we are responsible for the development cost and manufacturing cost. (in Canada, Mexico and S. Africa) Before we can sell it to other countries, we need the pproval first. And the only foreseeable trials are the ones in Canada. That means we are responsible for this cost. I guess we must sell AH now to raise the fund. And you can forget the dividend. All will go towards this gamble in Urocidin. 

Unless, we can come up with a U.S. company that is willing to fund the FDA trials in U.S. And the price (rights assignment) won't be cheap.

Any guess how much we can get the SP to even if all works out?

<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse